Cognitive Outcome After Islet Transplantation

Area of Science:

• Endocrinology
• Neuroscience
• Transplantation Immunology

Background:

• Severe or recurrent hypoglycemia in type 1 diabetes (T1D) can lead to memory issues.
• Pancreatic islet transplantation (IT) offers an alternative for T1D management, but associated immunosuppression may pose neurological risks.

Purpose of the Study:

• To compare cognitive function, assessed by the Mini-Mental State Examination (MMSE), between T1D patients with and without IT.
• To identify factors influencing MMSE scores in T1D patients undergoing IT.

Main Methods:

• A retrospective cross-sectional study compared MMSE and cognitive tests in T1D patients before and after IT, versus non-transplanted T1D controls.
• Forty-three T1D patients were analyzed, including 9 pre-IT and 34 post-IT (on mycophenolate or sirolimus-based immunosuppression).

Main Results:

• No significant difference in MMSE scores or higher cognitive functions was observed between islet-transplanted and non-transplanted T1D patients, irrespective of immunosuppressive regimen.
• In the overall cohort, MMSE scores negatively correlated with glycated hemoglobin and time spent in hypoglycemia.
• MMSE scores did not correlate with C-peptide levels, hyperglycemia, average glucose, duration of immunosuppression, diabetes duration, or IT success.

Conclusions:

• This study suggests that improved glucose balance, rather than immunosuppressive treatment, is crucial for cognitive function in T1D patients post-IT.
• Islet transplantation may favorably impact cognitive function by improving overall glucose control.